NCT07759271

Brief Summary

This single-center, prospective, four-arm randomized controlled trial will enroll 72 adults with chronic intestinal failure and low muscle mass. All participants will receive standardized basic nutritional support and will be randomly assigned to one of four groups: usual care, whey protein supplementation, resistance training, or whey protein supplementation combined with resistance training. Participants assigned to whey protein supplementation will receive 20 g of whey protein daily for 6 weeks. Participants assigned to resistance training will complete moderate-intensity resistance exercises for approximately 30 minutes, 3 to 5 times per week, for 6 weeks. Participants in the combined group will receive both interventions. Body composition, appendicular skeletal muscle mass index, phase angle, handgrip strength, 6-meter walking speed, laboratory indicators, and quality of life will be assessed at baseline, week 6, and week 8. The study aims to evaluate the effectiveness and safety of whey protein supplementation and resistance training, alone or in combination, for improving muscle mass and physical function in patients with chronic intestinal failure.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P50-P75 for not_applicable

Timeline
14mo left

Started Aug 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 5, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 12, 2026

Completed
16 days until next milestone

Study Start

First participant enrolled

August 28, 2026

Expected
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 28, 2027

2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 28, 2027

Last Updated

August 12, 2026

Status Verified

August 1, 2026

Enrollment Period

1 year

First QC Date

August 5, 2026

Last Update Submit

August 11, 2026

Conditions

Keywords

Chronic Intestinal FailureLow Muscle MassResistance TrainingAppendicular Skeletal Muscle Mass IndexPhysical Function

Outcome Measures

Primary Outcomes (1)

  • Change in Appendicular Skeletal Muscle Mass Index

    Baseline, Week 6, and Week 8

Study Arms (4)

Control Group

NO INTERVENTION

Participants will receive standardized basic nutritional support and usual clinical care without additional whey protein supplementation or protocol-specified resistance training.

Resistance Training Group

EXPERIMENTAL

Participants will receive standardized basic nutritional support and moderate-intensity resistance training for approximately 30 minutes per session, 3 to 5 times per week, for 6 weeks.

Other: Resistance Training Group

Combined Intervention Group

EXPERIMENTAL

Participants will receive standardized basic nutritional support, 20 g of whey protein orally once daily, and moderate-intensity resistance training for approximately 30 minutes per session, 3 to 5 times per week, for 6 weeks.

Other: Whey Protein Supplementation GroupOther: Resistance Training Group

Whey Protein Supplementation Group

EXPERIMENTAL
Other: Whey Protein Supplementation Group

Interventions

Participants will receive standardized basic nutritional support and 20 g of whey protein orally once daily for 6 weeks.

Combined Intervention GroupWhey Protein Supplementation Group

Participants will perform moderate-intensity resistance training for approximately 30 minutes per session, 3 to 5 times per week, for 6 weeks, in addition to standardized basic nutritional support.

Combined Intervention GroupResistance Training Group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with chronic intestinal failure and low muscle mass.
  • Willing to participate in the study and provide written informed consent.
  • Able to complete the assigned 6-week intervention and the assessments at baseline, week 6, and week 8.

You may not qualify if:

  • Known allergy to whey protein.
  • Severe renal dysfunction.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Intestinal Failure

Condition Hierarchy (Ancestors)

Intestinal DiseasesGastrointestinal DiseasesDigestive System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This is a four-arm, parallel-group randomized controlled trial evaluating whey protein supplementation and resistance training, each alone and in combination, compared with usual care.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

August 5, 2026

First Posted

August 12, 2026

Study Start (Estimated)

August 28, 2026

Primary Completion (Estimated)

August 28, 2027

Study Completion (Estimated)

October 28, 2027

Last Updated

August 12, 2026

Record last verified: 2026-08